Answers are grounded in this paper and cite their sources.
This expert consensus and review provides a comprehensive overview of ACH management, with a focus on the integration of vosoritide into routine pediatric care. It summarizes current evidence and clinical experience in the treatment of key complications, including neurosurgical (e.g., hydrocephalus, foramen magnum stenosis, spinal stenosis), orthopedic (e.g., thoracolumbar kyphosis, limb deformities), and otolaryngologic (e.g., otitis media, hearing loss, obstructive sleep apnea) domains. The review also highlights the role of rehabilitation in optimizing motor development, postural control, and functional independence. Practical guidance is provided on the early identification of clinical red flags, proactive interventions, multidisciplinary coordination, and monitoring of disease progression. Furthermore, the integration of vosoritide therapy into standard care is discussed, with emphasis on patient selection, team-based management, monitoring protocols, and emerging strategies for combining pharmacological and surgical approaches. This review and expert opinion aim to support clinicians in delivering personalized, evidence-based care for children with ACH, offering a comprehensive framework for current therapeutic strategies and the incorporation of vosoritide into multidisciplinary management.
No takes yet. Share an insight, caveat, or question.
Allegri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: